Inato operates a clinical trial platform designed to connect pharmaceutical sponsors with community-based research sites and patients. The platform functions as an AI-powered marketplace, facilitating partnerships between global pharmaceutical companies and researchers to broaden patient access to new medical treatments. It supports trial planning, site selection, and patient pre-screening.
The company's platform connects over 6,000 research sites in more than 50 countries. Inato's technical work involves AI, marketplace development, and clinical trial matching systems. The company has a presence in Neuilly-sur-Seine, France, and the United States, with a global operational footprint.
